ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection

Hui Zhang; Hong-Bao Li; Jian-Rui Lyu; Xiao-Ming Lei; Wei Li; Gang Wu; Jun Lyu; Zhi-Ming Dai
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES2020-7-1DOI: 10.1016/j.ijid.2020.04.027
26阅读
引用收藏
分享

摘要

<br/>The coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China and rapidly spread in other countries in December 2019. The infected patients presented with fever, respiratory symptoms, sometimes with digestive and other systemic manifestations, and some progressed with a severe acute respiratory syndrome or even death. Associated digestive symptoms were frequently observed in the patients, with an unknown significance and mechanism. ACE2, as the major known functional receptor of the 2019 novel coronavirus (2019-nCoV) attracted our attention. We collected the clinical data of the 2019-nCoV-infected patients from published studies and extracted the data about the incidence of gastrointestinal symptoms. Furthermore, we used online datasets to analyze ACE2 expression in different human organs, especially in the small intestine, to explore the relationship between ACE2 expression patterns and clinical symptoms. We found that diarrhea accounted for a notable proportion of COVID-19 patients, ranging from 8.0% to 12.9%. The results reveal that ACE2 mRNA and protein are highly expressed in the small intestinal enterocytes but not in the goblet cells or intestinal immune cells. High expression of ACE2 on the surface cells in the digestive tract may lead to gastrointestinal symptoms and inflammation susceptibility. Overall, digestive symptoms were common in the COVID-19 patients. ACE2 expression on surface cells of the small intestine may mediate the invasion and amplification of the virus and activation of gastrointestinal inflammation. It is a possible mechanism of digestive symptoms in the COVID-19 patients and explains the presence of the virus in patients’ stool samples. The study also highlights the necessity of taking stool samples for suspected patients to help in early diagnosis and assessment of disease status.

学科与关键词

关键词
2019-nCoVCOVID-19ACE2Small intestineDiarrhea
被引文献 (1)相关
加载中…
  • The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
    Craig M., Coopersmith; Massimo, Antonelli; Seth R., Bauer; Clifford S., Deutschman; Laura E., Evans; Ricard, Ferrer; Judith, Hellman; Sameer, Jog; Jozef, Kesecioglu; Niranjan, Kissoon; Ignacio, Martin-Loeches; Mark E., Nunnally; Hallie C., Prescott; Andrew, Rhodes; Daniel, Talmor; Pierre, Tissieres; Daniel, De BackerCritical Care Medicine, 2021, 49(4): 598-622.

发表信息

论文状态
公开发表
期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
发表日期
2020-07-01
卷期
第 96 卷
页码
19-24
DOI
10.1016/j.ijid.2020.04.027
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIENCEDIRECT

作者

  • H

    Hui Zhang (第一作者)

  • H

    Hong-Bao Li

查看全部 8 位作者收起作者
  • J

    Jian-Rui Lyu

  • X

    Xiao-Ming Lei

  • W

    Wei Li

  • G

    Gang Wu

  • J

    Jun Lyu

  • Z

    Zhi-Ming Dai

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417